-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
-
(2005)
CA Cancer J Clin.
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
84921817161
-
Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9
-
Zhang S, Wu L, Liu Q, Chen K, Zhang X. Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9. Onco Targets Ther. 2015;8:223-231.
-
(2015)
Onco Targets Ther.
, vol.8
, pp. 223-231
-
-
Zhang, S.1
Wu, L.2
Liu, Q.3
Chen, K.4
Zhang, X.5
-
3
-
-
84924719480
-
Serum galectin-3 as a potential marker for gastric cancer
-
Cheng D, Liang B, Li Y. Serum galectin-3 as a potential marker for gastric cancer. Med Sci Monit. 2015;21:755-760.
-
(2015)
Med Sci Monit.
, vol.21
, pp. 755-760
-
-
Cheng, D.1
Liang, B.2
Li, Y.3
-
4
-
-
84897514570
-
Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour
-
Wang YW, Shi DB, Chen X, Gao C, Gao P. Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour. PLoS One. 2014;9(3):e91307.
-
(2014)
PLoS One.
, vol.9
, Issue.3
-
-
Wang, Y.W.1
Shi, D.B.2
Chen, X.3
Gao, C.4
Gao, P.5
-
5
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
-
(2004)
Cell.
, vol.116
, Issue.2
, pp. 281-297
-
-
Bartel, D.P.1
-
6
-
-
3042767202
-
MicroRNAs: Small RNAs with a big role in gene regulation
-
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-531.
-
(2004)
Nat Rev Genet.
, vol.5
, Issue.7
, pp. 522-531
-
-
He, L.1
Hannon, G.J.2
-
7
-
-
0642285627
-
The microRNA world: Small is mighty
-
Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z. The microRNA world: small is mighty. Trends Biochem Sci. 2003;28(10):534-540.
-
(2003)
Trends Biochem Sci.
, vol.28
, Issue.10
, pp. 534-540
-
-
Nelson, P.1
Kiriakidou, M.2
Sharma, A.3
Maniataki, E.4
Mourelatos, Z.5
-
8
-
-
84919932140
-
Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer
-
Chen P, Xi Q, Wang Q, Wei P. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer. Med Oncol. 2014;31(10):235.
-
(2014)
Med Oncol.
, vol.31
, Issue.10
, pp. 235
-
-
Chen, P.1
Xi, Q.2
Wang, Q.3
Wei, P.4
-
9
-
-
60149084560
-
MicroRNAs and cancer: Short RNAs go a long way
-
Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586-591.
-
(2009)
Cell.
, vol.136
, Issue.4
, pp. 586-591
-
-
Ventura, A.1
Jacks, T.2
-
10
-
-
73349125465
-
MicroRNAs in cancer: Small molecules with a huge impact
-
Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848-5856.
-
(2009)
J Clin Oncol.
, vol.27
, Issue.34
, pp. 5848-5856
-
-
Iorio, M.V.1
Croce, C.M.2
-
11
-
-
33645294070
-
Oncomirs - microRNAs with a role in cancer
-
Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-269.
-
(2006)
Nat Rev Cancer.
, vol.6
, Issue.4
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
12
-
-
4644309196
-
The functions of animal microRNAs
-
Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-355.
-
(2004)
Nature.
, vol.431
, Issue.7006
, pp. 350-355
-
-
Ambros, V.1
-
13
-
-
84961288049
-
MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion
-
Zhang Z, Sun J, Bai Z, et al. MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion. Onco Targets Ther. 2015;8:357-364.
-
(2015)
Onco Targets Ther.
, vol.8
, pp. 357-364
-
-
Zhang, Z.1
Sun, J.2
Bai, Z.3
-
14
-
-
84864568344
-
Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm
-
Cheung TH, Man KN, Yu MY, et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012;11(15):2876-2884.
-
(2012)
Cell Cycle.
, vol.11
, Issue.15
, pp. 2876-2884
-
-
Cheung, T.H.1
Man, K.N.2
Yu, M.Y.3
-
15
-
-
64549124430
-
microRNA expression profile in undifferentiated gastric cancer
-
Katada T, Ishiguro H, Kuwabara Y, et al. microRNA expression profile in undifferentiated gastric cancer. Int J Oncol. 2009;34(2):537-542.
-
(2009)
Int J Oncol.
, vol.34
, Issue.2
, pp. 537-542
-
-
Katada, T.1
Ishiguro, H.2
Kuwabara, Y.3
-
16
-
-
70449602451
-
Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration
-
Lei Z, Li B, Yang Z, et al. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One. 2009;4(10):e7629.
-
(2009)
PLoS One.
, vol.4
, Issue.10
-
-
Lei, Z.1
Li, B.2
Yang, Z.3
-
17
-
-
85027935984
-
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
-
Zhou W, Shi G, Zhang Q, Wu Q, Li B, Zhang Z. MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). Cell Biosci. 2014;4(1):62.
-
(2014)
Cell Biosci.
, vol.4
, Issue.1
, pp. 62
-
-
Zhou, W.1
Shi, G.2
Zhang, Q.3
Wu, Q.4
Li, B.5
Zhang, Z.6
-
18
-
-
84930935659
-
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b
-
Ingwersen J, Menge T, Wingerath B, et al. Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b. Ann Clin Transl Neurol. 2015;2(1):43-55.
-
(2015)
Ann Clin Transl Neurol.
, vol.2
, Issue.1
, pp. 43-55
-
-
Ingwersen, J.1
Menge, T.2
Wingerath, B.3
-
19
-
-
84906896673
-
Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors
-
Yamaguchi T, Iijima T, Wakaume R, et al. Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors. Oncology. 2014;87(1):58-66.
-
(2014)
Oncology.
, vol.87
, Issue.1
, pp. 58-66
-
-
Yamaguchi, T.1
Iijima, T.2
Wakaume, R.3
-
20
-
-
84895556999
-
MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer
-
Zhu J, Chen L, Zou L, et al. MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum Immunol. 2014;75(4):348-353.
-
(2014)
Hum Immunol.
, vol.75
, Issue.4
, pp. 348-353
-
-
Zhu, J.1
Chen, L.2
Zou, L.3
-
21
-
-
84898639126
-
miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells
-
Saleiban A, Faxalv L, Claesson K, Jonsson JI, Osman A. miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells. Pigment Cell Melanoma Res. 2014;27(3):431-441.
-
(2014)
Pigment Cell Melanoma Res.
, vol.27
, Issue.3
, pp. 431-441
-
-
Saleiban, A.1
Faxalv, L.2
Claesson, K.3
Jonsson, J.I.4
Osman, A.5
-
22
-
-
84872687799
-
Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers
-
Li JY, Zhang Y, Zhang WH, et al. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. Asian Pac J Cancer Prev. 2012;13(5):1901-1906.
-
(2012)
Asian Pac J Cancer Prev.
, vol.13
, Issue.5
, pp. 1901-1906
-
-
Li, J.Y.1
Zhang, Y.2
Zhang, W.H.3
-
23
-
-
77952507643
-
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells
-
Cascio S, D'Andrea A, Ferla R, et al. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol. 2010;224(1):242-249.
-
(2010)
J Cell Physiol.
, vol.224
, Issue.1
, pp. 242-249
-
-
Cascio, S.1
D'Andrea, A.2
Ferla, R.3
-
24
-
-
61349141809
-
Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer
-
Wang CJ, Zhou ZG, Wang L, et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers. 2009;26(1):27-34.
-
(2009)
Dis Markers.
, vol.26
, Issue.1
, pp. 27-34
-
-
Wang, C.J.1
Zhou, Z.G.2
Wang, L.3
|